Levomefolate glucosamine 426 views0 applications

Australian approved name (AAN): Levomefolate glucosamine

Common names and synonyms:
(6S)-5-methyltetrahydrofolic acid glucosamine salt
(6S)-5-methylfolate glucosamine salt
Vitamin B9

Molecular formula: C32H51N9O16

Molecular weight: 817.80

Conversion (% Levomefolic acid): 56.18  (% Glucosamine): 43.81

RDI for Vitamin B9 as per NHMRC:
Infants – 0-6 months 65µg/day (as folate) (AI)
Infants – 7-12 months 80µg/day (AI)
Children – 1-3 years – 150µg/day
Children – 4-8 years – 200µg/day
Children – 9-13 years – 300µg/day
Children – 14-18 years – 400µg/day
Adults – 400µg/day
Pregnancy – 600µg/day
Lactation – 500µg/day

Maximum daily dose: The maximum recommended daily dose must provide no more than 500mcg of Levomefolic acid from Levomefolate glucosamine. When used in combination with folic acid, folinic acid and/or their derivatives, the medicine must not provide more than a total of 500 mcg of folic acid, folinic acid and/or their derivatives in total per maximum recommended daily dose.

Mandatory component: Levomefolic acid

Warnings and restrictions: Only for use in oral medicines.

VIT – Vitamins can only be of assistance if the dietary vitamin intake is inadequate. OR Vitamin supplements should not replace a balanced diet.

When used in preparations indicated for reducing the risk of having a child with spina bifida/neural tube defects:
a) the maximum daily dose must provide 400 – 500 micrograms of folic acid; and
b) the following statements must be included on the label:
NEUR – Warning: Do not exceed the stated dose except on medical advice. If you have had a baby with a neural tube defect/spina bifida – seek specific medical advice (or words to that effect)

Acceptance criteria for Levomefolate glucosamine  is 96 – 102% (on anhydrous basis), equivalent to (6S)-5-methyltetrahydro folic acid 53.8 – 57.1% (on anhydrous basis) and glucosamine 42.2 – 44.9% (on anhydrous basis).

Allowable purpose of the ingredient: Active

TGA reference:  CHEMID plus (National Library of Medicine)

Apply for this resource
Share this resource

Advanced Wellness Regulatory Solutions are a team of highly skilled professionals who specialise in providing timely and reliable regulatory and research & development advice.



While we take all measures to ensure that the information provided on this site is accurate, before relying on the material in any important matter, users should carefully evaluate its accuracy, completeness and relevance for their purposes, and should obtain any appropriate professional advice relevant to their particular circumstances.


Want to stay up to date with the latest industry changes and updates? Signup to our newsletter below.